MRK vs. PFE
Compare and contrast key facts about Merck & Co., Inc. (MRK) and Pfizer Inc. (PFE).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: MRK or PFE.
Correlation
The correlation between MRK and PFE is 0.39, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
MRK vs. PFE - Performance Comparison
Loading data...
Key characteristics
MRK:
-1.46
PFE:
-0.65
MRK:
-1.97
PFE:
-0.69
MRK:
0.74
PFE:
0.92
MRK:
-0.90
PFE:
-0.24
MRK:
-1.67
PFE:
-1.03
MRK:
23.41%
PFE:
13.71%
MRK:
27.67%
PFE:
24.45%
MRK:
-68.62%
PFE:
-58.96%
MRK:
-41.45%
PFE:
-55.78%
Fundamentals
MRK:
$187.83B
PFE:
$128.49B
MRK:
$7.00
PFE:
$1.42
MRK:
10.69
PFE:
15.92
MRK:
0.69
PFE:
0.57
MRK:
2.94
PFE:
2.06
MRK:
3.89
PFE:
1.42
MRK:
$63.92B
PFE:
$62.46B
MRK:
$51.75B
PFE:
$42.09B
MRK:
$27.30B
PFE:
$16.71B
Returns By Period
In the year-to-date period, MRK achieves a -22.88% return, which is significantly lower than PFE's -10.86% return. Over the past 10 years, MRK has outperformed PFE with an annualized return of 6.00%, while PFE has yielded a comparatively lower 0.61% annualized return.
MRK
-22.88%
-0.52%
-19.71%
-40.16%
3.11%
6.00%
PFE
-10.86%
5.56%
-4.64%
-15.78%
-4.34%
0.61%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
MRK vs. PFE — Risk-Adjusted Performance Rank
MRK
PFE
MRK vs. PFE - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Merck & Co., Inc. (MRK) and Pfizer Inc. (PFE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
MRK vs. PFE - Dividend Comparison
MRK's dividend yield for the trailing twelve months is around 4.15%, less than PFE's 7.45% yield.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
MRK Merck & Co., Inc. | 4.15% | 3.14% | 2.72% | 2.52% | 3.41% | 3.03% | 2.48% | 2.60% | 3.36% | 3.14% | 3.43% | 3.12% |
PFE Pfizer Inc. | 7.45% | 6.33% | 5.70% | 3.12% | 2.64% | 3.91% | 3.67% | 3.11% | 3.53% | 3.69% | 3.46% | 3.33% |
Drawdowns
MRK vs. PFE - Drawdown Comparison
The maximum MRK drawdown since its inception was -68.62%, which is greater than PFE's maximum drawdown of -58.96%. Use the drawdown chart below to compare losses from any high point for MRK and PFE. For additional features, visit the drawdowns tool.
Loading data...
Volatility
MRK vs. PFE - Volatility Comparison
Merck & Co., Inc. (MRK) has a higher volatility of 12.13% compared to Pfizer Inc. (PFE) at 9.58%. This indicates that MRK's price experiences larger fluctuations and is considered to be riskier than PFE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading data...
Financials
MRK vs. PFE - Financials Comparison
This section allows you to compare key financial metrics between Merck & Co., Inc. and Pfizer Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
MRK vs. PFE - Profitability Comparison
MRK - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Merck & Co., Inc. reported a gross profit of 12.11B and revenue of 15.53B. Therefore, the gross margin over that period was 78.0%.
PFE - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Pfizer Inc. reported a gross profit of 10.87B and revenue of 13.72B. Therefore, the gross margin over that period was 79.3%.
MRK - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Merck & Co., Inc. reported an operating income of 5.94B and revenue of 15.53B, resulting in an operating margin of 38.2%.
PFE - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Pfizer Inc. reported an operating income of 2.79B and revenue of 13.72B, resulting in an operating margin of 20.3%.
MRK - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Merck & Co., Inc. reported a net income of 5.08B and revenue of 15.53B, resulting in a net margin of 32.7%.
PFE - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Pfizer Inc. reported a net income of 2.97B and revenue of 13.72B, resulting in a net margin of 21.6%.